AI English summary of an SEC filing — figures as filed
Church & Dwight said it signed a definitive agreement to sell its VitaFusion® and L'il Critters® brands to Piping Rock Health Products, Inc. on December 9, 2025. The company said it expects the deal to close within the year.
Key points
AI summaryChurch & Dwight said it signed a definitive agreement to sell its VitaFusion® and L'il Critters® brands to Piping Rock Health Products, Inc. on December 9, 2025. The company said it expects the deal to close within the year.
The company said the sale includes related trademarks and licenses, as well as its manufacturing and distribution facilities in Vancouver and Ridgefield, Washington. It said the deal is subject to customary closing conditions.
The company said the VMS brands account for less than 5% of its anticipated 2025 net sales, which is 2025 estimated figure. It said the transaction is expected to result in a one-time, after-tax charge of $40 million to $45 million in Q4 2025, net of proceeds, reflecting a non-cash impairment and transition and transaction costs.
The company said it has completed its strategic review of its vitamin, mineral and supplement (VMS) business. Chief Executive Officer Rick Dierker said the sale strengthens the company's portfolio and allows more focus on its remaining power brands.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Church & Dwight Agrees to Sell VitaFusion and L'il Critters Brands
Church & Dwight said it signed a definitive agreement to sell its VitaFusion® and L'il Critters® brands to Piping Rock Health Products, Inc. on December 9, 2025. The company said it expects the deal to close within the year.
Source · Based on the filing body and exhibits
Sale Covers Trademarks, Licenses and Washington State Facilities
The company said the sale includes related trademarks and licenses, as well as its manufacturing and distribution facilities in Vancouver and Ridgefield, Washington. It said the deal is subject to customary closing conditions.
Source · Based on the filing body and exhibits
VMS Brand Share and Q4 One-Time Charge Outlook
The company said the VMS brands account for less than 5% of its anticipated 2025 net sales, which is 2025 estimated figure. It said the transaction is expected to result in a one-time, after-tax charge of $40 million to $45 million in Q4 2025, net of proceeds, reflecting a non-cash impairment and transition and transaction costs.
Source · Based on the filing body and exhibits
VMS Strategic Review Concluded and CEO Comments
The company said it has completed its strategic review of its vitamin, mineral and supplement (VMS) business. Chief Executive Officer Rick Dierker said the sale strengthens the company's portfolio and allows more focus on its remaining power brands.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…